Healthcare Distribution Alliance – Patients Move Us.
Share Print



Results: 73 Articles found.
  • HDMA Op-Ed: Collaboration Vital to Further Progress on Key Supply Chain Issues
    February 8, 2016

    Collaboration will continue to be the key to a healthy supply chain in 2016, writes HDMA President and CEO John M. Gray in a new opinion piece published in the January/February issue of Pharmaceutical Commerce magazine. In particular, Gray writes that, “Collaboration has been most evident in the way the supply chain has tackled two of our industry’s toughest issues — traceability and prescription drug abuse.”

  • HDMA Comments on Release of Medicaid AMP Final Rule
    January 28, 2016

    HDMA President and CEO John M. Gray issued the following statement on the Centers for Medicare & Medicaid Services’ (CMS) final rule implementing Affordable Care Act changes to Medicaid rebates, the Average Manufacturer Price (AMP) and Federal Upper Limits under the Medicaid Covered Outpatient Drug Program. The rule, referred to as the “AMP rule,” will go into effect on April 1, 2016, with state Medicaid agencies receiving an additional year to adapt their respective programs to the regulation.

  • HDMA is One of the Best Places to Work in Virginia for Sixth Consecutive Year
    January 5, 2016

    For the sixth year in a row, the Healthcare Distribution Management Association (HDMA) has been named one of 100 Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.

  • Pharmaceutical Distributors Provide Essential Services to Specialty Rx Supply Chain
    December 21, 2015

    New research published by the Center for Healthcare Supply Chain Research, HDMA’s knowledge partner, indicates that pharmaceutical distributors provide the specialty pharmaceutical supply chain essential services while efficiently aggregating and delivering thousands of lifesaving medications to a large network of providers for the treatment of critically ill patient populations with chronic or rare diseases.

  • 91.4 Percent of U.S. Pharmaceutical Sales Channeled Through HDMA-Member Distributors
    December 16, 2015

    Approximately 91 percent of pharmaceutical products — about $350 billion — came to market through HDMA-member traditional pharmaceutical distributors in 2014, according to the 86th Edition HDMA Factbook: The Facts, Figures and Trends in Healthcare (2015-2016). This represents a 1.3 percentage point increase from 2013. Meanwhile, the Factbook notes that spending on pharmaceuticals continues to rise in the U.S., reaching about $374 billion in 2014, according to IMS Health.

Website design and development by, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | P | O365